After you’ve gone through ovarian cancer treatment, your doctor will work with you to make sure you stay well. But sometimes the cancer returns. Doctors call this “recurrence.” To check for ...

If you have ovarian cancer, your outcomes will be better if you are treated by a gynecologic oncologist right from the beginning. Fred Hutch Cancer Center has more gynecologic oncologists than any ...

Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at ...

A new drug is showing promise in tackling treatment-resistant ovarian cancer. Relacorilant, the drug tested in a phase 3 ROSELLA trial with Corcept Therapeutics in California, was found to improve ...

A panelist discusses how National Comprehensive Cancer Network (NCCN) guidelines have influenced molecular testing in ovarian cancer, highlighting the importance of biomarkers like BRCA genes for ...

That means an ovarian cancer patient could receive an intravenous injection and have her tumor stop growing following one 30-minute, non-invasive magnetic field session. Short treatment sessions ...

Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can accurately choose more effective treatments and lead to improved outcomes for ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC ... likely to be missed and potentially receive delayed treatment. In fact, study authors found that falsely ...

Corcept Therapeutics shares nearly doubled in premarket trading Monday after the company said it received positive data from its phase 3 ovarian cancer treatment trial. Shares rose 93% ahead of the ...

said epithelial ovarian cancer often initially responds to chemotherapy treatment and then enters a period of resistance to therapy and tumor regrowth. "This is partly due to the selection and ...